Avadel Pharmaceuticals plc - stock earnings
AVDL Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -28.8 million USD | 19.5 million USD |
2023Q3 | -36.3 million USD | 7.0 million USD |
2023Q2 | -64.4 million USD | 1.5 million USD |
2023Q1 | -30.8 million USD | ? USD |
2022Q4 | -27.5 million USD | ? USD |
2022Q3 | -20.1 million USD | ? USD |
2022Q2 | -63.4 million USD | ? USD |
2022Q1 | -26.4 million USD | ? USD |
2021Q4 | -22.3 million USD | ? USD |
2021Q3 | -22.0 million USD | ? USD |
2021Q2 | -19.6 million USD | ? USD |
2021Q1 | -13.4 million USD | ? USD |
2020Q4 | -11.3 million USD | ? USD |
2020Q3 | -11.7 million USD | 14.2 million USD |
2020Q2 | 30.9 million USD | 10.1 million USD |
2020Q1 | -865000 USD | 12.2 million USD |
2019Q4 | -2.7 million USD | 11.0 million USD |
2019Q3 | -8.9 million USD | 14.2 million USD |
2019Q2 | -8.6 million USD | 17.6 million USD |
2019Q1 | -13.0 million USD | 16.4 million USD |
2018Q4 | -63.9 million USD | 20.9 million USD |
2018Q3 | -15.8 million USD | 19.8 million USD |
2018Q2 | -3.4 million USD | 29.2 million USD |
2018Q1 | -12.2 million USD | 33.3 million USD |
2017Q4 | -9.3 million USD | 34.2 million USD |
2017Q3 | 21.7 million USD | 39.7 million USD |
2017Q2 | 28.9 million USD | 46.3 million USD |
2017Q1 | 25.9 million USD | 52.5 million USD |
2016Q4 | 4.7 million USD | 43.1 million USD |
2016Q3 | -22.3 million USD | 32.1 million USD |
2016Q2 | -20.0 million USD | 38.9 million USD |
2016Q1 | -6.4 million USD | 36.2 million USD |
2015Q4 | 76.1 million USD | 43.4 million USD |
2015Q3 | -29.7 million USD | 47.3 million USD |
2015Q2 | -17.4 million USD | 49.8 million USD |
2015Q1 | -27.1 million USD | -9.5 million USD |
2014Q4 | -27.1 million USD | -9.5 million USD |
2014Q3 | -10.0 million USD | 7.0 million USD |
2014Q2 | -21.1 million USD | 8.1 million USD |
2014Q1 | -26.6 million USD | 9.2 million USD |
2013Q4 | 5.1 million USD | 6.2 million USD |
2013Q3 | 5.1 million USD | 6.2 million USD |
2013Q2 | -32.9 million USD | 5.5 million USD |
2013Q1 | -8.8 million USD | 5.1 million USD |
2012Q4 | 9.1 million USD | 7.3 million USD |
2012Q3 | -6.4 million USD | 5.4 million USD |
2012Q2 | -1.3 million USD | 6.1 million USD |
2012Q1 | 12000 USD | 7.4 million USD |
2011Q4 | -2.1 million USD | 8.6 million USD |
2011Q3 | 1.7 million USD | 10.4 million USD |
2011Q2 | -3.5 million USD | 6.8 million USD |
2011Q1 | 2.7 million USD | 13.5 million USD |
2010Q4 | 2.7 million USD | 13.5 million USD |
2010Q3 | -4.6 million USD | 11.0 million USD |
2010Q2 | -4.3 million USD | 7.5 million USD |
2010Q1 | -5.7 million USD | 10.6 million USD |
2009Q4 | -5.7 million USD | 10.6 million USD |
2009Q3 | -3.4 million USD | 9.9 million USD |
2009Q2 | -3.4 million USD | 9.9 million USD |
2009Q1 | -2.7 million USD | 9.5 million USD |
2008Q4 | -2.7 million USD | 9.5 million USD |
2008Q3 | -2.3 million USD | 9.1 million USD |
2008Q2 | -2.3 million USD | 9.1 million USD |
2008Q1 | -5.9 million USD | 10.6 million USD |
2007Q4 | -5.9 million USD | 10.6 million USD |
2007Q3 | -9.1 million USD | 9.0 million USD |
2007Q2 | -9.1 million USD | 9.0 million USD |
2007Q1 | -9.1 million USD | 9.6 million USD |
2006Q4 | -5.9 million USD | 7.8 million USD |
2006Q3 | -10.2 million USD | 5.4 million USD |
2006Q2 | -9.5 million USD | 4.7 million USD |
2006Q1 | -6.4 million USD | 6.3 million USD |
2005Q4 | -6.4 million USD | 6.3 million USD |
2005Q3 | -11.9 million USD | 3.1 million USD |
2005Q2 | -9.2 million USD | 6.1 million USD |
2005Q1 | 9.8 million USD | 32.1 million USD |
2004Q4 | 9.8 million USD | 32.1 million USD |
2004Q3 | -1.6 million USD | 9.0 million USD |
2004Q2 | -1.6 million USD | 9.0 million USD |
2004Q1 | 1.7 million USD | 11.3 million USD |
2003Q4 | 1.7 million USD | 11.3 million USD |
2003Q3 | -1.9 million USD | 5.4 million USD |
2003Q2 | -1.7 million USD | 5.0 million USD |
2003Q1 | -327000 USD | 2.4 million USD |
2002Q4 | -327000 USD | 2.4 million USD |
2002Q3 | 2.4 million USD | 6.4 million USD |
2002Q2 | -1.7 million USD | 5.0 million USD |
2002Q1 | -79000 USD | 4.6 million USD |
2001Q4 | -79000 USD | 4.6 million USD |
2001Q3 | -666000 USD | 2.6 million USD |
2001Q2 | -1.4 million USD | 2.4 million USD |
2001Q1 | -769000 USD | 3.5 million USD |
2000Q4 | 3.5 million USD | 2.9 million USD |
2000Q3 | -1.0 million USD | 3.0 million USD |
2000Q2 | -990000 USD | 2.8 million USD |
2000Q1 | -6.3 million USD | 2.0 million USD |
1999Q4 | 2.2 million USD | 7.0 million USD |
1999Q3 | -3.0 million USD | 1.7 million USD |
1999Q2 | -3.0 million USD | 1.0 million USD |
1999Q1 | -2.9 million USD | 1.3 million USD |
1998Q4 | -1.6 million USD | 2.9 million USD |
1998Q3 | -2.2 million USD | 1.7 million USD |
1998Q2 | -1.6 million USD | 2.7 million USD |
1998Q1 | -2.4 million USD | 2.2 million USD |
1997Q4 | 100000 USD | 3.4 million USD |
1997Q3 | -2.9 million USD | 1.2 million USD |
1997Q2 | -2.2 million USD | 1.3 million USD |
1997Q1 | -1.7 million USD | 2.1 million USD |
1996Q4 | -1.6 million USD | 1.2 million USD |
1996Q3 | -1.4 million USD | 700000 USD |
1996Q2 | -2.4 million USD | 900000 USD |
1996Q1 | -1.5 million USD | 2.1 million USD |
AVDL Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -160.3 million USD | 28.0 million USD |
2022 | -137.5 million USD | 1.5 million USD |
2021 | -77.3 million USD | ? USD |
2020 | 7.0 million USD | 22.3 million USD |
2019 | -33.2 million USD | 59.2 million USD |
2018 | -95.3 million USD | 103.3 million USD |
2017 | 67.3 million USD | 172.7 million USD |
2016 | -41.3 million USD | 150.2 million USD |
2015 | 40.7 million USD | 173.2 million USD |
2014 | -84.9 million USD | 14.8 million USD |
2013 | -42.9 million USD | 22.4 million USD |
2012 | -3.2 million USD | 26.1 million USD |
2011 | -8.8 million USD | 32.6 million USD |
2010 | -9.0 million USD | 37.1 million USD |
2009 | -11.4 million USD | 42.1 million USD |
2008 | -12.1 million USD | 38.6 million USD |
2007 | -37.7 million USD | 36.7 million USD |
2006 | -35.2 million USD | 23.0 million USD |
2005 | -27.4 million USD | 23.6 million USD |
2004 | 12.5 million USD | 55.4 million USD |
2003 | -3.5 million USD | 25.2 million USD |
2002 | 3.0 million USD | 18.4 million USD |
2001 | -2.9 million USD | 13.1 million USD |
2000 | -9.5 million USD | 10.9 million USD |
1999 | -6.7 million USD | 11.0 million USD |
1998 | -7.8 million USD | 9.5 million USD |
1997 | -6.8 million USD | 8.1 million USD |
1996 | -6.9 million USD | 4.9 million USD |
AVDL
Price: $18.82
52 week price:
Earnings Per Share: -2.00 USD
P/E Ratio: -6.70
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 237800
Ebitda: 27.2 millionMarket Capitalization: 1.5 billion